소개글
[국제경영전략] 녹십자(영문)에 대한 자료입니다.
목차
1. Introduction
- The prospect of BT industry
- Case Study: A fresh outbreak of H1N1 pandemic
- Vaccine market overview
2. Analysis
- Green Cross in the Vaccine market
- SWOT analysis
- External analysis: competitors
- Strategies
3. Conclusion and References
- Future plans based on its core competence
본문내용
◎ Green Cross in the vaccine market
Green Cross is a R&D-oriented company that leads the Korean biotechnology industry since its foundation in 1967. Starting from the nation's first production and sales of Plasma Fractions in 1970, which required sophisticated technology, Green Cross has striven to develop ethical drugs that are hard to produce but essential to patients. Subsequently, it is now an internationally recognized biotechnology company in the fields of plasma fractions and vaccine.
In 2009, the only vaccine specialized factory in Korea, ‘Hwasun factory’ was completed. Total 67 million dollars was invested in the factory and the maximum annual production is 50 million doses. The annual demand of flu-vaccine is 15 million doses on average.
◎ SWOT analysis
Green Cross has accumulated a technological know-how of vaccine production. For example, it has developed a world’s second chickenpox vaccine. Its early mover advantage on the vaccine is a entry barrier itself. And it also has its own R&D institutes such as Mogam Biotechnology Research Institute.
Green Cross is relying on the ETC and specialty medicine which cannot guarantee the total market share. In other words, it is too risky to keep its sales for a long time only with these few ETC and specialty medicines.
- Vista of Mogam Biotechnology Research Institute and researcher (R&D capability)
The reason why Korea shows low self-sufficiency of vaccine is because importing from overseas is more profitable than starting vaccine business by oneself. Since it has strong competence in vaccine production, Green Cross should be successful.
A stable supplying of eggs is a crucial for the vaccine production process because it is a raw material for the vaccine. But only clean fertilized eggs can be used to make vaccines. There are not many poultry farms that produce this kind of eggs and moreover it takes more than 8 months to get them. So this is one of the
참고문헌
1. 바이오인 - http://www.bioin.or.kr/
2. LG 투자증권 이승호 연구원 분석 리포트 - http://www.greencross.com/